New research reveals that people who discontinue new GLP-1 drugs like semaglutide or tirzepatide may regain shed pounds far faster than those who end traditional diet and exercise programs.
Research printed in a prominent health publication points out that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the mass comes back at an estimated rate of 0.8 kg per month after stopping.
"People buying these drugs must be informed of the potential of fast weight regain when the therapy concludes," stated expert Dr. Susan Jebb.
That rate of regain means a return to original mass within about one and a half years.
Comparing Therapies
The analysis, which looked at dozens of studies involving over 9,000 of participants, compared the results of the injectable medications with other pills.
Scientists point out that people who lose weight through lifestyle changes alone generally have a slower creep back—approximately 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Nutrition scientists believe the mechanism of the injections explains the amplified rebound.
These medications mimic a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations several times higher than the body's typical production may cause the system to generate a reduced amount of its endogenous GLP-1, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Discontinuation of this hormone supplement leads to hunger is no longer kept in check, making overeating far more likely."
An Ongoing Disease?
Health authorities recommend the injections for people with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Many experts contend that, given the high risk of relapse, the therapy might need to be life-long.
This view is reinforced by drug manufacturers, who note that the findings "emphasize the chronic character of excess weight," akin to managing conditions like high blood pressure.
Patient Testimonies
Individuals who have discontinued the jabs describe a powerful resurgence of hunger.
"I experienced something activating and you're instantly extremely hungry," said an individual.
This challenge is exacerbated if users have not adopted lasting lifestyle or habit modifications during treatment.
Significant Interest
Figures suggest that millions of adults in the UK have tried weight-loss jabs in the past year, with interest remaining high.
- Use is greater among women compared to men.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private prescriptions rather than the NHS.
Ultimately, experts caution that while the jabs are effective tools for weight loss, they are not a permanent cure and lasting health benefits relies on ongoing behavioural support.